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Reporting quality – The weakest link?Planning, running and reporting clinical trials is a multi-
faceted, multidisciplinary activity: its purpose is to reduce un-
certainties about treatment effects and improve the delivery
of healthcare to individuals. Any shortcoming or breakdown
of any one part of that activity – administration; governance;
management; execution; data collection and recording;
reporting and dissemination – will affect the quality of the
transference of information and evidence into practice. The
published report is the vehicle for conveying what was
learned from the trial to those who will use that information
and data to benefit patients. Authors of trial reports firstly
need to be able to access full and accurate trial information
and data in order to clearly describe the ‘what, why, when
and how’ of a trial’s activity. Secondly, they must present
these facts clearly, fully and comprehensively, both to do
justice to the expenditure and efforts of all those involved –
patients and health professionals alike – and in order to
provide a full picture of what occurred and what was found
to all those readers who will use the findings. Not only will
practicing health professionals need to fully understand how
the trial was conducted and what its findings were in order
to interpret, debate and use the findings properly, but so
also will those people involved in conducting systematic re-
views. Randomised controlled trials (RCTs) are the building
blocks of knowledge: they should visibly be of the highest
possible quality.
1. The CONSORT statement
Authors of trial reports have been provided with a tool to as-
sist them in covering all essential information. The CONSORT
statement1 (http://www.consort-statement.org/) comprises
a 22-item checklist and a flow diagram, along with some brief
descriptive text. The checklist items focus on reporting how
the trial was designed, analysed, and interpreted; the flow
diagram displays the progress of all participants through the
trial. The Statement has been translated into several lan-
guages. The CONSORT statement is kept under review by
the executive and updated as necessary (http://www.consort-
statement.org/index.aspx?o¼1399). Revision of the last
updated version (2001)2 is currently being planned.2. Reporting quality of RCTs – the ‘building
blocks’ of knowledge
Alarming findings from a systematic review of the reporting
quality of 90 urology RCTs in surgery are reported in this issue:
(pp xx–xx) they show that the standard of reporting is unac-
ceptably low.3 The average score for compliance against the
main checklist of 22 items was only 11.1. The authors draw at-
tention to particular problems with surgical trials, but urge
that it is therefore doubly important that surgical trials should
be scrupulously reported. It was disturbing to note that com-
pliance was very poor in reporting objectives; randomisation
implementation; outcomes and estimation; and interpretation
within the discussion section. The greatest concern was that
not one urological trial described how their process of random-
isation was achieved. Other systematic reviews of quality of
reporting in other specialties have found similar worrying
shortcomings.4,5,6 As authors of another systematic review
stated ‘‘Inadequate reporting can create difficulties with interpreta-
tion and can lead to biased results receiving false credibility.’’7
Improving healthcare for patients by testing treatments in
RCTs depends upon the inter-dependent efforts of a wide
range of people and organisations. It is important that
methods and findings from RCTs are reported clearly, accu-
rately and fully. The CONSORT statement, plus four additional
items, has been developed to ensure that all necessary aspects
of a trial’s activity and findings are covered in trial reports and
publications. It has been available for a decade. Why then are
authors, reviewers, journal editors, funding bodies, sponsors,
trial planners and management teams not taking advantage
of this valuable tool that would sharpen the reporting quality
of emerging evidence? Why do authors not feel a responsibility
to present, properly and fully, the proceeds of so much time,
thought, money and effort? Do they not feel a moral obligation
or a sense of accountability to make a full and accurate ac-
count for numerous medical colleagues and to the patients
for whom this activity has been undertaken?
3. A wake-up call
The findings from this systematic review of the reporting qual-
ity of RCTs in urological surgery and five other non-urological
specialties3 should provide a wake-up call to all who write
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score of 11.1/22 against the CONSORT checklist found in this
systematic review, with no publication achieving full compli-
ance, not only suggests a poor understanding by authors of
what elements are essential to convey to readers in their pub-
lished reports if they are to get a full picture of what occurred,
but also begs the question of what urgent action must be taken
to educate to achieve a more conscientious approach. Further-
more, whose responsibility should this be? Unless this respon-
sibility is acknowledged, debated and claimed, it is likely that
little improvement in reporting quality will occur.
4. Possible solutions
How then might this serious problem be addressed? It is essen-
tial that trials be registered at their outset.8 Sponsors, trial
funding organisations and academic institutions could do
more to ensure that ultimate publication and dissemination
of trial findings will be to a high standard. Standard operating
procedures for efficient trial management should be set up.9
Proposals for bids could not only require potential researchers’
plans for publication, but also suggest that researchers should
use the CONSORT Statement to ensure that the description of
the methodology they propose to use covers all necessary
items and aspects. This, in the long run, would also make it eas-
ier for authors of reports to ensure that the findings would be
fully reported. Adequate funding must be available to cover
proper management, administration and recording of data.
All journals ‘instructions to authors’ should stipulate that au-
thors reporting RCTs should use the CONSORT checklist. Re-
viewers’ instructions could include a link to the CONSORT
statement and a request to check that it has been used. The tri-
al’s independent Data Monitoring Committee (DMC) could also
encourage full and proper reporting of all data covering all en-
rolled participants. But the most effective strategy for improve-
ment would be to cultivate a culture where every contributing
individual would recognise the importance of a scrupulous and
conscientious attention to detail.
The public expect high standards of professionalism and
good common sense from health professionals. This profes-
sionalism should extend to all fields of endeavour that
comprise today’s practice of good quality evidence-based
medicine. This pre-supposes adequate education and training
for all health professionals who are in the business of reduc-
ing uncertainty about treatments by thorough research. This
systematic review3 indicates a sad attitude to a necessary
businesslike approach to fully communicate what researchers
have done and what they have found. It is time for change.
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